Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19
Clinical trial NCT04412538 · COMPLETED
Trial details
- NCT number
- NCT04412538
- Sponsor
- Institute of Medical Biology, Chinese Academy of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-15
- Primary completion
- 2020-08-10
- Enrollment
- 942
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.